Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
September 2008
September 2
Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
Novartis Decides Not to Pursue Further Development of Aurograb
Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before November 2011
ZymoGenetics Earns Milestone Payment for RECOTHROM European Filing
Value of Direct-to-Consumer Drug Advertising Oversold, Study Finds
America's Pharmaceutical Research Companies Respond to Hurricane Gustav's Landfall
Takeda and Affymax Provide Clinical Development Update for Hematide in Chemotherapy-Induced Anemia
HIV/AIDS Update - Updated Labeling for Norvir (ritonavir) Soft Capsule and Oral Solution
IVAX Diagnostics Reports Sale of Parent Company's Interest
September 3
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Consumer Reports Urges Chronic Headache Sufferers to Examine Their Use of Pain Relief Drugs
GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza
Léger Survey Reports 84 Per Cent of Ontario Physicians Feel Patients May Be Addicted to Prescription Painkillers
Study: Teen Suicide Spike Was No Fluke
Merck and ZymoGenetics Restructure Partnership
Zentiva N.V. – Sanofi Offer Update
September 4
September 5
Phase Forward Acquires Clarix LLC, Innovation Leader in Web-Integrated Interactive Response Technology (IRT) for Clinical Trials
Free Drug Samples May End Up Costing Uninsured More
Inauguration of the Sanofi-Aventis Central Anti-Counterfeit Laboratory in Tours
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Reps. Dingell, Stupak Write Schering-Plough and Merck on Vytorin-Cancer Link
Prescription Drug Advertising Subject of New FDA Web Site for Consumers
FDA to Post Quarterly Report of Potential Safety Issues
September 8
September 9
Pharmas Challenged by Product Risk and Philanthropy Fatigue
Pharmas Challenged by Product Risk and Philanthropy Fatigue
SDI Reports: Prescribers May Influence Patient Adherence by Authorizing More Refills
Federal Court of Appeals in a Divided Decision Reverses District Court Ruling Dismissing Vioxx Securities Class Action
Solvay Pharmaceuticals Acquires Innogenetics
September 10
September 11
Cell Genesys Reconfirms Plans with FDA for Phase 3 Program for GVAX Immunotherapy While on Partial Clinical Hold
King to Commence Cash Tender Offer for Alpharma at $37 Per Share
Bristol-Myers Squibb Submits Letter to ImClone Board of Directors
Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
FDA MedWatch- Rituxan (rituximab)- Important New Safety Information Regarding Progressive Multifocal Leukoencephalopathy With The Use Of Rituxan
Alpharma Urges Shareholders to Take No Action with Respect to King Pharmaceuticals' Announced Intent to Commence a Tender Offer
September 12
ARIAD Announces Merger with ARIAD Gene Therapeutics, Inc.
ImClone Systems Submits Letter to Bristol-Myers Squibb
King Commences Cash Tender Offer for Alpharma at $37 Per Share
NACDS 2008 Chain Pharmacy Industry Profile Showcases Extraordinary Impact of Pharmacies as a Frontline Healthcare Provider, Significantly Impacting Economy
September 15
WebMD to Acquire QualityHealth.com
Betaseron to Offer the Thinnest Needle in Multiple Sclerosis
Online Video is an Emerging Channel for Physicians to Connect with Pharmaceutical Companies
Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia
SeraCare Life Sciences Announces Completion of SEC Investigation
Teva Announces Appellate Court Reverses Generic Risperdal Exclusivity Decision
Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options
Cybercitizen Health Europe Study Reveals How European Consumers Use the Internet for Health Information
September 16
Charles River Acquires MIR Preclinical Services
Bayer HealthCare Acquires German DIREVO Biotech AG
GSK and XenoPort Announce Submission of NDA Requesting FDA Approval of Solzira for Restless Legs Syndrome
MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
Cytokinetics Announces Strategic Realignment of Workforce and Operations
September 17
FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
Biovail Acquires Prestwick Pharmaceuticals
ViRexx Announces Failure to Secure an Alternative Equivalent Funder to Replace LM Funds Corp.
Information on the Removal From Office of Mr. Gerard Le Fur and the Appointment of Mr. Chris Viehbacher as Chief Executive Officer
Ranbaxy, Statement on FDA Letters
André Hoffmann Acquires Expanded Position in MedAssurant and Joins Board of Directors
September 18
Neose Technologies to Sell its Assets to Novo Nordisk and BioGeneriX
Ranbaxy Laboratories, Ltd., Retains Former New York City Mayor Rudy Giuliani to Lead Team in Resolution of Issues Raised by U. S. Food & Drug Administration
SCT Receives Letter From Health Canada and Verbal Request From FDA to Place a Clinical Hold on Its REGENESIS Phase IIb Stroke Trial
September 19
September 22
Encorium Announces the Initiation of a Strategic Partnership With Prologue Research
Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
Angiotech Announces Reorganization and Cost Reduction Initiatives, Updates Financial Outlook
Med Ad News Names Novartis Pharmaceutical Company of the Year
AstraZeneca Receives Six Months Pediatric Exclusivity for Casodex (bicalutamide) from the FDA
Proposed Class Action Settlement and Class Certification Regarding Wholesale Drug Pricing May Affect Consumers and Third-Party Payors
September 23
Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share
Half of Trials Supporting FDA Applications Go Unpublished
FDA MedWatch - Tarceva (erlotinib) - Cases of Hepatic Failure and Hepatorenal Syndrome, Including Fatalities, Have Been Reported During Use of Tarceva
Icahn Responds to Cornelius
September 24
FDA Warns Companies to Stop Marketing Unapproved Ophthalmic Balanced Salt Solution Drug Products and Topical Drug Products Containing Papain
Roche Completes Acquisition of ARIUS
Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments
Elias A. Zerhouni to End Tenure as Director of the National Institutes of Health
September 25
Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
Medicis Announces Intent to Restate Financial Statements
NICE Guidelines are Set to Improve Care and Management of Children, Young People and Adults With ADHD
Canon Communications’ R&D Directions Magazine Wins Bronze Eddie Award
AARP Rx Watchdog Report Finds Specialty Drug Prices Soar
September 26
Alpharma Board of Directors Unanimously Rejects King Pharmaceuticals' Unsolicited Tender Offer as "Financially Inadequate"
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Online European Consumers Turn to Search Engines and Wikipedia for Health Information
Crucell's Swiss Affiliate Berna Biotech to Cease All Animal Testing
FDA MedWatch - Epoetin alfa- Preliminary Safety Findings Show More Deaths In Patients Given Epoetin-alpha Versus Placebo
September 29
Cardinal Health Plans to Spin Off Clinical and Medical Products Businesses, Creating Global Leader in Medical Technology
WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
FDA Issues Several Letters for ADHD Drugs
FDA Continues to Review Prasugrel New Drug Application
FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
ImClone Systems Issues Statement
Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices
